C105H138BBr4Cl5K2N26O7 — CID 158539903
dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate (PubChem CID 158539903) has the molecular formula C105H138BBr4Cl5K2N26O7 and a molecular weight of 2462.32 g/mol. Its IUPAC name is dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate.
| Compound Name | dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate |
|---|---|
| PubChem CID | 158539903 |
| Molecular Formula | C105H138BBr4Cl5K2N26O7 |
| Molecular Weight | 2462.32 g/mol |
| Exact Mass | 2454.58 |
| IUPAC Name | dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate |
| SMILES | Brc1ccc2cn[nH]c2c1.CN1CCN(CCCn2ncc3ccc(-c4cc(Nc5ccc(Cl)cc5)nc(N5CCOCC5)n4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(B4OC(C)(C)C(C)(C)O4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(Br)cc32)CC1.CN1CCNCC1.ClCCCBr.ClCCCn1ncc2ccc(Br)cc21.Clc1ccc(Nc2cc(Cl)nc(N3CCOCC3)n2)cc1.O=CO[O-].[H-].[K+].[K+] |
| InChI | InChI=1S/C29H35ClN8O.C21H33BN4O2.C15H21BrN4.C14H14Cl2N4O.C10H10BrClN2.C7H5BrN2.C5H12N2.C3H6BrCl.CH2O3.2K.H/c1-35-11-13-36(14-12-35)9-2-10-38-27-19-22(3-4-23(27)21-31-38)26-20-28(32-25-7-5-24(30)6-8-25)34-29(33-26)37-15-17-39-18-16-37;1-20(2)21(3,4)28-22(27-20)18-8-7-17-16-23-26(19(17)15-18)10-6-9-25-13-11-24(5)12-14-25;1-18-7-9-19(10-8-18)5-2-6-20-15-11-14(16)4-3-13(15)12-17-20;15-10-1-3-11(4-2-10)17-13-9-12(16)18-14(19-13)20-5-7-21-8-6-20;11-9-3-2-8-7-13-14(5-1-4-12)10(8)6-9;8-6-2-1-5-4-9-10-7(5)3-6;1-7-4-2-6-3-5-7;4-2-1-3-5;2-1-4-3;;;/h3-8,19-21H,2,9-18H2,1H3,(H,32,33,34);7-8,15-16H,6,9-14H2,1-5H3;3-4,11-12H,2,5-10H2,1H3;1-4,9H,5-8H2,(H,17,18,19);2-3,6-7H,1,4-5H2;1-4H,(H,9,10);6H,2-5H2,1H3;1-3H2;1,3H;;;/q;;;;;;;;;2*+1;-1/p-1 |
| InChIKey | IQGCYDRRSIEUTE-UHFFFAOYSA-M |
| XLogP | 11.98 |
| TPSA | 303.05 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 150 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2462.32 |
| LogP ≤ 5 | 11.98 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 32 |
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'} |
|---|